Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
This article is authored by Dr Amrit Kaur Kaler, consultant, molecular pathology, Kokilaben Dhirubhai Ambani Hospitals, ...
Acting as a crucial interface, or bridge between the Van Gogh’s camera and its PC, is a BitFlow Cyton CXP4 CoaXPress 1.1 compliant quad-link frame grabber. It maintains image quality and prevents data ...
The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and ...
Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, ...
According to Precedence Research, the global RNA analysis market size is expected to be worth USD 23.39 billion by 2035, increasing from USD 10.21 billion in 2026, with a strong CAGR of 9.65% from ...
The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and projected to reach US$3.7 billion ...
Drug resistance continues to limit the long-term benefit of many targeted therapies and chemotherapies against cancer. While “classical” small-molecule ...
FDA orphan designation for zenocutuzumab‑zbco targets NRG1 fusion–positive advanced cholangiocarcinoma, a small molecular subset within an aggressive malignancy with <15% five-year survival. Orphan ...
A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled scientists for years.
Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance SheetUNIONDALE, NY, Feb. 03, 2026 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results